Table 1.
Patient 1 | Patient 2 | Patient 3 | Patient 4 | |
---|---|---|---|---|
Age at diagnosis (months) | 3 | 18 | 7 | Birth |
Death | No | No | No | No |
Family history | Unremarkable | Unremarkable | Unremarkable | One brother affected |
Symptoms | Macrocephaly, hydrocephaly, growth retardation, pale optic nerve papillae, fever, rhinitis, mild hypotony | Macrocephaly, hydrocephaly, growth retardation, pale optic nerve papillae, hepato-splenomegaly, dysmorphism, pale skin, muscle ipotony, and ipotrophy | Macrocephaly, dwarfism, severely reduced vision, hepato-splenomegaly, nistagmo | Macrocephaly, reduced vision, ipotony, mild hepato-splenomegaly, mild ipoacusy |
Surgery | Anterior craniotomy for decompression | No | No | Optic channel decompression |
Pre-BMT therapy | Vitamin D3 135 ng/kg/day | No | Prednisone 1mg/kg/day | No |
Age at BMT (months) | 6 | 21 | 9 | 2 |
Donor (bone marrow) | Sister | Unrelated | Unrelated | Brother |
GVHD | Yes | Yes | No | No |
Post-BMT follow-up | Marked improvement of osteosclerosis | Growth retardation | Severely compromised vision (both eyes) | Vision left eye <1/50 |